“We are honored to host an event that features such talented and ingenious people. Their level of merit and innovation is truly inspiring, and we have high hopes for this year’s event,” states ISHLT Program Chair, Jason D. Christie MD, MS.
Dallas (PRWEB) March 21, 2014
The full list of speakers for the International Society for Heart and Lung Transplantation’s (ISHLT) 34th Annual Meeting and Scientific Sessions has been released.
Joining the Nobel Prize winner Alvin E. Roth, Ph.D., Professor of Economics at Stanford University, USA, and Lifetime Achievement Award Recipient Sir Terence English, KBE, FRCS, from Oxford, United Kingdom, are Eric Topol, MD, of The Scripps Translational Science Institute in La Jolla, Calif,; Lynne W. Stevenson, MD, of Brigham & Women’s Hospital in Boston, Mass.; and Tomas M. Egan, MD, MSC of the University of North Carolina School of Medicine in Chapel Hill, NC.
Dr. Topol, voted as the number one influential physician executive in the United States in 2012, will give a lecture on how “Digitizing Humans Changes the Future of Medicine.” Dr. Topol has worked to expand the understanding of how genetics can determine a person’s health risks, particularly the risk for a heart attack, and has been the spearhead in the discovery of multiple genes that increase susceptibility for heart attack.
Dr. Stevenson, who is also a Professor of Medicine at Harvard Medical School, will speak at this year’s event on the subject of “Trimming Heart Transplantation in the VAD Era.” Stevenson’s investigative focus is on the elucidation of principles for the therapy of patients with heart failure.
Dr. Egan, who has been involved for years in guiding U.S. policy on organ allocation, engages in active research on expanding the donor pool using new ex-vivo lung perfusion techniques, in which lungs are placed for evaluation and possible treatment before transplant. A recent recipient of a $1.47 million NIH grant for research into using these techniques in non-heart beating donors, Dr. Egan, will discuss “Frontiers of DCD in Thoracic Transplantation.”
“We are honored to host an event that features such talented and ingenious people. Their level of merit and innovation is truly inspiring, and we have high hopes for this year’s event,” states ISHLT Program Chair, Jason D. Christie MD, MS.
The 34th annual ISHLT event will take place in San Diego, Calif., on April 10-30, 2014. For more information visit http://www.ishlt.org.
The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit professional organization with more than 2,700 members from over 45 countries dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies via research, education and advocacy. For more information, visit http://www.ishlt.org.
###